Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

CNBC

BusinessCNBC·Aug 2, 2026·1 min read

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

View original source — CNBC ↗

ShareShare on X Share on Facebook

Related stories

Electronic Arts misses quarterly bookings estimates ahead of Saudi-backed buyout

BusinessAug 3, 2026 · 1 min

Electronic Arts misses quarterly bookings estimates ahead of Saudi-backed buyout

South Korea July inflation +2.8% y/y, weaker than expected

BusinessAug 3, 2026 · 1 min

South Korea July inflation +2.8% y/y, weaker than expected

CNBC's The China Connection newsletter: AI wins come with an old investor risk

BusinessAug 3, 2026 · 1 min

CNBC's The China Connection newsletter: AI wins come with an old investor risk

Australia's Qantas to exit Jetstar Japan in $52 million share buyback deal

BusinessAug 3, 2026 · 1 min

Australia's Qantas to exit Jetstar Japan in $52 million share buyback deal